2021
Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in Hospice
Prater LC, O’Rourke B, Schnell P, Xu W, Li Y, Gustin J, Lockwood B, Lustberg M, White S, Happ MB, Retchin SM, Wickizer TM, Bose-Brill S. Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in Hospice. American Journal Of Hospice And Palliative Medicine® 2021, 39: 504-510. PMID: 34427154, DOI: 10.1177/10499091211039449.Peer-Reviewed Original ResearchConceptsAdvance care planningDays of lifeHospital admissionAdvanced cancerCare planningACP servicesCross-sectional retrospective cohort studySystematic advance care planningLife hospital admissionsMedical claims analysisRetrospective cohort studyAdvanced cancer patientsInpatient hospital admissionsPopulation of patientsAdvanced cancer diagnosisQuality of careHospice referralCohort studyIBM MarketScanEOL outcomesInpatient admissionsStudy criteriaCancer patientsHospice careCare preferencesImpact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer.
Takvorian S, Parikh R, Vader D, Wileyto E, Clark A, Lee D, Goyal G, Rocque G, Dotan E, Geynisman D, Phull P, Spiess P, Kim R, Davidoff A, Gross C, Miksad R, Calip G, Shulman L, Mamtani R, Hubbard R. Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer. Journal Of Clinical Oncology 2021, 39: 1528-1528. DOI: 10.1200/jco.2021.39.15_suppl.1528.Peer-Reviewed Original ResearchAdvanced solid cancersTreatment initiationAdvanced cancer diagnosisAdvanced cancerSolid cancersCancer typesCox proportional hazards modelCOVID-19 pandemicSystemic therapy initiationSystemic treatment initiationTimely care deliveryDe novo cancerDe novo diseaseAdvanced breast cancerCancer diagnosisLife-prolonging therapiesProportional hazards modelInterrupted time series analysisDe-identified databaseProbability of treatmentNovo diseaseTherapy initiationNovo cancerPerformance statusClinical outcomes
2019
Palliative care referral patterns of adolescent and young adult patients at a comprehensive cancer center.
Lockwood B, Ntukidem O, Ehrman S, Lustberg M, Bhatnagar B, Klemanski D. Palliative care referral patterns of adolescent and young adult patients at a comprehensive cancer center. Journal Of Clinical Oncology 2019, 37: 63-63. DOI: 10.1200/jco.2019.37.31_suppl.63.Peer-Reviewed Original ResearchAYA populationPalliative careComprehensive cancer centerReferral patternsPC referralAYA patientsCancer CenterOncology careCancer diagnosisComprehensive oncology careIntegrative palliative carePost-discharge followRetrospective chart reviewYoung adult patientsAdvance care planningAdvanced cancer diagnosisQuality of lifeNational Cancer InstituteAYA cancerInpatient referralsPalliative servicesAdult patientsChart reviewPC clinicsOncologic treatment
2016
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Schrader K, Cheng D, Joseph V, Prasad M, Walsh M, Zehir A, Ni A, Thomas T, Benayed R, Ashraf A, Lincoln A, Arcila M, Stadler Z, Solit D, Hyman D, Zhang L, Klimstra D, Ladanyi M, Offit K, Berger M, Robson M. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. JAMA Oncology 2016, 2: 1-8. PMID: 26556299, PMCID: PMC5477989, DOI: 10.1001/jamaoncol.2015.5208.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkers, TumorDNA Mutational AnalysisFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGerm-Line MutationHumansMaleMiddle AgedModels, GeneticNeoplasmsNew York CityPhenotypePrecision MedicinePredictive Value of TestsPrognosisRisk AssessmentRisk FactorsConceptsTumor-normal sequencingPathogenic germline variantsGermline variantsAdvanced cancer diagnosisClinical tumor sequencingCancer susceptibility genesTumor sequencingMemorial Sloan Kettering Cancer CenterStudies of targeted agentsIndividual cancer typesTumor genetic sequencingGermline findingsProportion of individualsTumor-specific variantsMendelian disease genesTargetable genetic alterationsCancer susceptibilityMatched normal DNACancer diagnosisTargeted tumor sequencingSingle-gene disordersCancer CenterMSK-IMPACTTumor profilingSomatic alterations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply